Search for: "Eli Lilly & Co."
Results 861 - 880
of 1,004
Sorted by Relevance
|
Sort by Date
18 Mar 2010, 2:30 am
(Patent Docs) (GenericsWeb) (patentcircle) Temodar (Temozolomide) – US: Teva announces parties to patent litigation regarding Barr’s US generic Temodar have entered into agreement pending resolution of Schering’s appeal to CAFC over ‘291 patent unenforceability finding (SmartBrief) Trilipix (Fenofibrate) – US: Impax Laboratories confirms challenge to Abbott and Fournier’s listed patent relating to Trilipix delayed-release capsules, 135 mg and 45 mg (SmartBrief)… [read post]
22 Mar 2010, 12:17 pm
Eli Lilly and Co. [read post]
25 Sep 2017, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
28 Sep 2011, 2:00 am
Armitage’s, of Eli Lilly and Company, presentation entitled ”A New 102: Reform, Not Recodification”…. [read post]
30 Nov 2021, 9:36 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
10 May 2017, 10:41 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
29 Mar 2011, 12:33 pm
Eli Lilly & Co., 736 F.Supp.2d 219, 222-23 (D.D.C. 2010); White v. [read post]
25 Mar 2011, 11:43 am
See Eli Lilly, 251 F.3d at 962. [read post]
24 Oct 2011, 9:36 am
Eli Lilly and Co., No. 2008-1248 (Fed. [read post]
27 Aug 2012, 1:31 pm
Eli Lilly & Co, 99 F.R.D. 126, 128 (D.D.C. 1983)).Similarly, the court addressed the notion that a treater serving as an expert witness for the defense would somehow violate a fiduciary duty to her patient/plaintiff, a duty that supposedly involved assisting the plaintiff in litigation. [read post]
6 Oct 2017, 2:34 pm
Eli Lilly, the court reaffirmed that written description is determined based on the state of the art as of a patent’s priority date and that evidence which illuminates the state of the art only subsequent to the priority date is not relevant to written description. [read post]
6 Nov 2020, 7:16 am
” (quoting appellant’s brief); See also Eli Lilly and Co. v. [read post]
20 Jun 2024, 12:23 pm
Eli Lilly & Co. [read post]
19 Feb 2021, 2:28 am
This second appeal followed with Bristol Myers Squibb Co., Pfizer Inc., and Eli Lilly and Company, among others, filing dueling amicus briefs. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist'… [read post]
28 Feb 2011, 8:19 am
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
7 Sep 2008, 2:47 pm
However, it is good to see that at least one manufacturer, Eli Lilly was one of the first to volunteer transparency in its financial dealings with health care providers. [read post]
21 Jul 2010, 9:09 am
http://tinyurl.com/2ebwzx5 Eli Lilly Co. v. [read post]
14 Oct 2007, 7:52 pm
The court agreed stating: While the Supreme Court has characterized infringement as defined in the Hatch-Waxman Act as "highly artificial," see Eli Lilly & Co. v. [read post]
28 Jul 2010, 12:06 am
K-V Pharmaceutical Co. et al. [read post]
